Type 2 Diabetes and the Brain in Adolescents

Nemours Children's Health

Status: Completed

Conditions: Hyperglycemia; Type 2 Diabetes Mellitus; Insulin Resistance; Dysglycemia; Obesity; Pediatric Obesity

Treatments: Procedure: Hyperglycemic clamp; Procedure: Hyperinsulinemic Euglycemic clamp

Study type: Interventional

Funder types: Other

Identifiers

NCT03461510

17-35

Details and patient eligibility

About

This study evaluates differences in brain function and cognitive performance in adolescents with type 2 diabetes (T2D) compared to non diabetic controls (both obese and lean) and correlates these changes with obesity, insulin resistance, and glycemic control in youth with T2D.

Full description

This is a cross-sectional study examining neurocognitive function and brain activity in resting state and during working memory and executive function tasks using blood oxygen level dependent (BOLD) functional MRI (fMRI) during hyperinsulinemic euglycemic and hyperglycemic clamps in obese adolescents with T2D compared to non-diabetic obese and lean controls. The investigators will measure glycemic control (acute hyperglycemia during clamps and glycemic variability) and insulin resistance to examine their association with neurocognitive metrics and brain functional activity.

There will be one screening visit and three study visits for subjects with T2D. One visit will consist of neurocognitive testing and dual energy X-ray absorptiometry (DEXA) of the whole body to assess body composition including fat mass. In the other two visits, subjects with T2D will undergo normal and high glucose clamps during fMRI.

Obese and lean control subjects will have one screening visit and two study visits, one for neurocognitive testing and DEXA and another for fMRI without glucose clamps. All subjects will have a blood sample obtained at the screening visit.

Only adolescents with type 2 diabetes will wear a continuous glucose monitor (CGM) for 6 days prior to neuroimaging to determine glycemic variability. A1C will be assessed at baseline.

Parents of subjects will also have abbreviated IQ testing.

Enrollment: 18 patients

Sex: All

Ages: 12 to 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Type 2 Diabetes:

• BMI ≥85th percentile
• A1c ≥ 8%
• Pubertal

Healthy Controls:

• BMI ≥85th percentile for Obese Controls
• BMI < 85th percentile for Lean Controls
• Pubertal
• Normal A1c & Fasting glucose

Exclusion criteria

• Significant developmental delay or learning disability
• Significant visual or auditory deficits
• Born <34 weeks gestation
• Neurologic disease
• Psychiatric disease requiring inpatient treatment
• Significant head trauma
• Malignancy
• Pregnancy
• Weight > 350lb (MRI weight limit)
• Metal in the body (including dental braces)

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

18 participants in 3 patient groups

Type 2 Diabetes

Experimental group

Description:

Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp

Treatment:

Procedure: Hyperinsulinemic Euglycemic clamp

Procedure: Hyperglycemic clamp

Lean Control

No Intervention group

Description:

Controls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp

Obese Control

No Intervention group

Description:

Controls do not undergo Hyperglycemic clamp and Hyperinsulinemic Euglycemic clamp